tiprankstipranks
QuidelOrtho Updates 2024 Financial Guidance and Outcomes
Company Announcements

QuidelOrtho Updates 2024 Financial Guidance and Outcomes

QuidelOrtho (QDEL) has released an update.

QuidelOrtho Corporation has revealed its financial outcomes for Q4 and the entire year of 2023, along with adjusted projections for 2024. The updated 2024 financial guidance anticipates total revenues between $2.76 and $3.07 billion, with non-respiratory revenue contributing $2.30 to $2.34 billion, and respiratory revenue between $460 and $730 million. Adjusted EBITDA is expected to range from $565 to $720 million, which translates to 21-24% of their total revenue, while adjusted diluted EPS is projected to be between $1.88 and $3.60.

For further insights into QDEL stock, check out TipRanks’ Stock Analysis page.

Related Articles
Sheryl ShethClass Action Lawsuit Against QuidelOrtho Corp. (NASDAQ:QDEL)
TheFlyQuidelOrtho opens new distribution center in Pedricktown, NJ
TheFlyJana took new positions in Wolfspeed and QuidelOrtho during Q1
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!